SNPs associated with AML treatment success
Credit: Guillaume Paumier
The presence of certain single-nucleotide polymorphisms (SNPs) can help signal which acute myeloid leukemia (AML) patients will benefit from treatment with gemtuzumab ozogamicin (GO), according to a study published in Clinical Cancer Research.
Notify me when a comment is posted for this article
In This Section